Cart
sales@molnova.com
BTT-266
CAS No. 2413939-89-4
BTT-266( —— )
Catalog No. M28487 CAS No. 2413939-89-4
BTT-266 is a blocker of voltage-gated calcium channel for pain management.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 590 | Get Quote |
|
| 25MG | 1060 | Get Quote |
|
| 50MG | 1591 | Get Quote |
|
| 100MG | 2387 | Get Quote |
|
| 200MG | 3580 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBTT-266
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTT-266 is a blocker of voltage-gated calcium channel for pain management.
-
DescriptionBTT-266 is a blocker of voltage-gated calcium channel for pain management.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorPKC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2413939-89-4
-
Formula Weight556.61
-
Molecular FormulaC34H28N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC=C(C2=NN(C(=O)C3=CC(C(=O)O)=CC=C3)C(C3=CN(C4=CC=CC=C4)N=C3C3=CC=C(C)C=C3)C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(S)-(-)-Bay-K-8644
(S)-(-)-Bay-K-8644 is an agonist of L-type Ca2+ channel and activates Ba2+ currents with an EC50 of 32 nM.
-
CBD3063
CBD3063 is a CRMP2-based peptidomimetic small molecule with analgesic and neuroprotective effects, which can allosterically regulate Cav 2.2 and can be used to study neurological diseases.
-
(±)-Liquiritigenin
(±)-Liquiritigenin ((±)-4',7-Dihydroxyflavanone), a flavonoid extracted from Angelica keiskei, inhibits the calcium-activated chloride channel TMEM16A.(±)-Liquiritigenin induces an increase in apoptosis and an enhancement of caspase3 activity.
